SCHEMBL1947533

SCHEMBL1947533

c1cncc(-c2cn3nc(NCc4cccs4)sc3n2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 7/20 0.64
LMNA P02545 1/20 0.53
KMT2A Q03164 5/20 0.52
CYP1A2 P05177 4/20 0.52
CYP3A4 P08684 4/20 0.52
CYP2D6 P10635 4/20 0.52
CLK4 Q9HAZ1 4/20 0.52
MEN1 O00255 3/20 0.52
ALOX15 P16050 2/20 0.52
HSD17B10 Q99714 2/20 0.52
F2 P00734 4/20 0.52
KLKB1 P03952 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ALDH1A1 P00352 4/20 0.51
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
GAA P10253 1/20 0.50
MAPK1 P28482 1/20 0.50
POLB P06746 2/20 0.47
PKM P14618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1946216 0.89 FYN (0.60) FYNLMNAALOX15HSD17B10SMN1; SMN2
SCHEMBL1944817 0.88 TP53 (0.51) FYNLMNAKMT2AMEN1ALOX15
SCHEMBL1945033 0.86 FYN (0.54) FYNHSD17B10F2KLKB1SMN1; SMN2
SCHEMBL1944440 0.84 FYN (0.62) FYNLMNAKMT2ACYP1A2CYP3A4
SCHEMBL1945139 0.83 FYN (0.50) FYNLMNAALOX15HSD17B10F2
SCHEMBL1946089 0.82 FYN (0.68) FYNLMNAKMT2ACYP1A2CYP3A4
SCHEMBL1947359 0.82 FYN (0.65) FYNLMNAKMT2AHSD17B10F2
SCHEMBL1945524 0.82 F2RL3 (0.53) FYNLMNAHSD17B10F2SMN1; SMN2
SCHEMBL2252346 0.82 FYN (0.47) FYNLMNACLK4ALOX15HSD17B10
SCHEMBL1945530 0.82 FYN (0.49) FYNALOX15HSD17B10F2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307425-B1 IMIDAZOTHIADIAZOLES DERIVATIVES MERCK PATENT GMBH (DE) 2014-03-26 EP claimed
EP-2307425-B1 IMIDAZOTHIADIAZOLES DERIVATIVES MERCK PATENT GMBH (DE) 2014-03-26 EP disclosed
US-8389554-B2 Imidazothiadiazole derivatives MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 2013-03-05 US disclosed
US-20110130396-A1 IMIDAZOTHIADIAZOLE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130396-A1 IMIDAZOTHIADIAZOLE DERIVATIVES TGFBR1, TGFBR2, IGF1R FYN 1977/4885LMNA 3477/4885KMT2A 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.